Clinical Trials Browser

Phase 3 × Recruiting × folfirinox × Clear all

NCT06714604 2024-12-03

ADVANTAGE

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05529940 2024-11-27

NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)

Phase 3 Recruiting

Gastrointestinal

Resectable Pancreatic Cancer